ID   KTCTL-26
AC   CVCL_5872
SY   KTCTL26; RCC-FG1; RCCFG1
DR   CLS; 300248
DR   Wikidata; Q54900642
RX   PubMed=8086765;
RX   PubMed=10190320;
RX   PubMed=15977034;
RX   PubMed=28196595;
WW   https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Omics: Protein expression by reverse-phase protein arrays.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300248
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 14,17
ST   D21S11: 29,30
ST   D3S1358: 16
ST   D5S818: 10,11,12
ST   D7S820: 10,11,12
ST   D8S1179: 12,13,15
ST   FGA: 19,23
ST   Penta D: 9,13
ST   Penta E: 12,17,18
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5873 ! KTCTL-26A
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
RX   PubMed=8086765; DOI=10.1007/BF00252823;
RA   Gross A.J., Wolff M., Fandrey J., Miersch W.-D.E., Dieckmann K.-P.,
RA   Jelkmann W.;
RT   "Prevalence of paraneoplastic erythropoietin production by renal cell
RT   carcinomas.";
RL   Clin. Investig. 72:337-340(1994).
//
RX   PubMed=10190320; DOI=10.1007/s004320050252;
RA   Frank M.H., Pomer S.;
RT   "Interferon alpha2b differentially affects proliferation of two human
RT   renal cell carcinoma cell lines differing in the
RT   P-glycoprotein-associated multidrug-resistant phenotype.";
RL   J. Cancer Res. Clin. Oncol. 125:117-120(1999).
//
RX   PubMed=15977034; DOI=10.1007/s10334-005-0107-7;
RA   Lutz N.W., Franks S.E., Frank M.H., Pomer S., Hull W.E.;
RT   "Investigation of multidrug resistance in cultured human renal cell
RT   carcinoma cells by 31P-NMR spectroscopy and treatment survival
RT   assays.";
RL   MAGMA 18:144-161(2005).
//
RX   PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005;
RA   Li J., Zhao W., Akbani R., Liu W.-B., Ju Z.-L., Ling S.-Y., Vellano C.P.,
RA   Roebuck P., Yu Q.-H., Eterovic A.K., Byers L.A., Davies M.A., Deng W.-L.,
RA   Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D.,
RA   Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y.-L., Mills G.B.,
RA   Liang H.;
RT   "Characterization of human cancer cell lines by reverse-phase protein
RT   arrays.";
RL   Cancer Cell 31:225-239(2017).
//